| 2022 |
β-Blockers and the Risk of Depression: A Matched Case-Control Study
10.1007/s40264-021-01140-5
Authors: D. Bornand, D. Reinau, S. Jick, C. Meier |
| 2021 |
β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score matched cohort study
10.1093/rheumatology/keab234
Authors: G. Nakafero, M. Grainge, A. Valdes, N. Townsend, C. Mallen, W. Zhang, M. Doherty, M. Mamas, A. Abhishek |
| 2018 |
Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink
10.1371/journal.pone.0207183
Authors: A. Jain, J. Walker, R. Mathur, H. Forbes, S. Langan, L. Smeeth, A. van Hoek, S. Thomas |
| 2021 |
Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study
10.1007/s00198-021-05862-1
Authors: J. Erwin, D. Enki, A. Woolf |
| 2019 |
Workload impact of the Quality and Outcomes Framework for patients with diabetes: an interrupted time series in general practice
10.3399/bjgp19X704645
Authors: C. Gilbert, V. Allgar, T. Doran |
| 2021 |
Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study
10.1210/clinem/dgab392
Authors: T. Berni, C. Morgan, D. Rees |
| 2024 |
Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study
10.1016/j.jinf.2024.106135
Authors: A. Lalmohamed, R. Venekamp, A. Bolhuis, P. Souverein, Jhhm van de Wijgert, M. Gulliford, A. Hay |
| 2014 |
Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework
10.1136/bmj.g330
Authors: E. Kontopantelis, D. Springate, D. Reeves, D. Ashcroft, J. Valderas, T. Doran |
| 2004 |
Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database
10.1093/pubmed/fdh160
Authors: M. Ashworth, R. Latinovic, J. Charlton, K. Cox, G. Rowlands, M. Gulliford |
| 1998 |
Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database
Authors: J. Bashford, J. Norwood, S. Chapman |
| 2003 |
Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation
Authors: C. Yang, S. Jick, M. Testa |
| 2016 |
Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study
10.3899/jrheum.151024
Authors: J. Robson, A. Kiran, J. Maskell, A. Hutchings, N. Arden, B. Dasgupta, W. Hamilton, A. Emin, D. Culliford, R. Luqmani |
| 2017 |
Where are the opportunities for an earlier diagnosis of primary intracranial tumours in children and young adults?
10.1016/j.ejpn.2016.10.010
Authors: T. Chu, A. Shah, D. Walker, M. Coleman |
| 2016 |
When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data
10.1182/blood-2015-01-625582
Authors: A. Walker, J. West, T. Card, C. Crooks, C. Kirwan, M. Grainge |
| 2019 |
What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study
10.1136/bmjopen-2018-028201
Authors: P. Tiffin, J. Mediavilla, H. Close, A. Kasim, P. Welsh, L. Paton, J. Mason |
| 2019 |
What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
10.1186/s12916-019-1307-8
Authors: A. McGovern, J. Dennis, B. Shields, A. Hattersley, E. Pearson, A. Jones |
| 2012 |
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes
10.1210/jc.2012-3034
Authors: C. Morgan, C. Poole, M. Evans, A. Barnett, S. Jenkins-Jones, C. Currie |
| 2020 |
What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right Patient
10.1007/s13300-020-00834-w
Authors: W. Strain, C. Tsang, M. Hurst, P. McEwan, M. Unadkat, S. Meadowcroft, R. Shardlow, M. Evans |
| 2015 |
What is the risk of having a total hip or knee replacement for patients with lupus?
10.1177/0961203314547894
Authors: S. Mukherjee, D. Culliford, N. Arden, C. Edwards |
| 2020 |
What is the optimal blood pressure level for patients with atrial fibrillation treated with direct oral anticoagulants?
10.1097/hjh.0000000000002487
Authors: J. Minhas, B. Coles, A. Mistri, D. Eveson, S. Hussain, J. Potter, K. Khunti, T. Robinson |
| 2021 |
What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?
10.1093/rheumatology/keab254
Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, W. Zhang, M. Doherty, M. Taal, G. Aithal, A. Abhishek |
| 2019 |
What is the incidence of late detection of developmental dysplasia of the hip in England?
10.1302/0301-620x.101b3.bjj-2018-1331.r1
Authors: C. Broadhurst, A. Rhodes, P. Harper, D. Perry, N. Clarke, A. Aarvold |
| 2018 |
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink
10.1186/s13195-018-0379-6
Authors: V. Walker, N. Davies, P. Kehoe, R. Martin |
| 2008 |
What is the harm-benefit ratio of Cox-2 inhibitors?
10.1093/ije/dym296
Authors: T. van Staa, L. Smeeth, I. Persson, J. Parkinson, H. Leufkens |
| 2004 |
What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? - description of trends in antimicrobial usage using the General Practice Research Database
10.1093/pubmed/fdh179
Authors: G. Smith, S. Smith, H. Heatlie, J. Bashford, J. Hawker, D. Ashcroft, D. Millson, N. Verlander, R. Warren |
| 2009 |
What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records
10.1111/j.1468-2982.2009.01872.x
Authors: D. Kernick, S. Stapley, J. Campbell, W. Hamilton |
| 2020 |
What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records data
10.1136/bmjopen-2020-037719
Authors: H. Strongman, R. Williams, K. Bhaskaran |
| 2015 |
What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
10.1136/bmjopen-2015-009665
Authors: N. Davies, G. Taylor, A. Taylor, K. Thomas, F. Windmeijer, R. Martin, M. Munafo |
| 2020 |
Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes
10.1097/ede.0000000000001196
Authors: C. Santella, H. Yin, B. Hicks, O. H. Y. Yu, N. Bouganim, L. Azoulay |
| 2021 |
Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database
10.1038/s41366-021-00788-4
Authors: C. Haase, S. Lopes, A. Olsen, A. Satylganova, V. Schnecke, P. McEwan |
| 2021 |
wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study
10.1136/bmjopen-2021-055219
Authors: B. Torlinska, J. Hazlehurst, K. Nirantharakumar, G. Thomas, J. Priestley, S. Finnikin, P. Saunders, K. Abrams, K. Boelaert |
| 2021 |
Weight change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental illness: protocol of a population-based cohort study in the UK from 1998 to 2020
10.1136/bmjopen-2021-053427
Authors: C. Lee, F. Waite, M. Smith, M. Gao, C. Bankhead, P. Aveyard, C. Piernas |
| 2012 |
Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs
10.1111/j.1463-1326.2011.01552.x
Authors: C. Morgan, S. Jenkins-Jones, M. Evans, A. Barnett, C. Poole, C. Currie |
| 2023 |
Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database
10.1111/dom.15154
Authors: K. MedSci, V. Schnecke, C. Haase, N. Harder-Lauridsen, N. Rathor, K. Sommer, C. Morgen |
| 2016 |
Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class
10.1111/ijcp.12746
Authors: B. Blak, U. Rigney, C. Sternhufvud, J. Davis, N. Hammar |
| 2019 |
Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study
10.1016/j.pan.2019.03.006
Authors: A. Mueller, C. Meier, S. Jick, C. Schneider |
| 2011 |
Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?
10.1111/j.1463-1326.2011.01413.x
Authors: L. Watson, B. Wilson, J. Alsop, S. Kumar |
| 2021 |
Vertebral fracture as a risk factor for self-harm: a retrospective cohort study
10.1186/s12891-021-04631-9
Authors: J. Prior, F. Crawford-Manning, R. Whittle, A. Abdul-Sultan, C. Chew-Graham, S. Muller, T. Shepherd, A. Sumathipala, C. Mallen, Z. Paskins |
| 2016 |
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson\textquoterights disease
10.1111/bcp.12964
Authors: C. Renoux, S. Dell'Aniello, P. Khairy, C. Marras, S. Bugden, T. Turin, L. Blais, H. Tamim, C. Evans, R. Steele, C. Dormuth, P. Ernst |
| 2019 |
Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy
10.1503/cmaj.180717
Authors: A. Sultan, S. Muller, R. Whittle, E. Roddy, C. Mallen, L. Clarson |
| 2017 |
Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis
10.1136/bmjopen-2016-012665
Authors: I. Little, Y. Vinogradova, E. Orton, J. Kai, N. Qureshi |
| 2023 |
Venous thromboembolism following colectomy for diverticular disease: an English population-based cohort study
10.1007/s00423-023-02920-6
Authors: Akds Yapa, D. Humes, C. Crooks, C. Lewis-Lloyd |
| 2004 |
Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database
10.1002/pds.896
Authors: H. Seaman, C. de Vries, R. Farmer |
| 2017 |
Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis
10.1186/s12885-017-3719-1
Authors: U. Khan, A. Walker, S. Baig, T. Card, C. Kirwan, M. Grainge |
| 2007 |
Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database
10.1111/j.1464-410X.2007.06859.x
Authors: H. Seaman, S. Langley, R. Farmer, C. de Vries |
| 2000 |
Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?
Authors: R. Lawrenson, R. Farmer |
| 2002 |
Venous leg ulcer: incidence and prevalence in the elderly
Authors: D. Margolis, W. Bilker, J. Santanna, M. Baumgarten |
| 2005 |
Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000
Authors: M. Ashworth, J. Charlton, K. Ballard, R. Latinovic, M. Gulliford |
| 2014 |
Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England
Authors: A. Walker, J. West, T. Card, D. Humes, M. Grainge |
| 2015 |
Variation in the risk of venous thromboembolism following colectomy
10.1002/bjs.9923
Authors: D. Humes, A. Walker, J. Blackwell, B. Hunt, J. West |
